Logo
x

Search

Subscribe Now

All Posts by Date

Biogen Reports Results of Spinraza (nusinersen) in P-II NURTURE Study as a Foundation of Care in Spinal Muscular Atrophy

Biogen Reports Results of Spinraza (nusinersen) in P-II NURTURE Study as a Foundation of Care in Spinal Muscular Atrophy

  • July 2, 2019
Regeneron and Sanofi's Libtayo (cemiplimab) Receives European Commission's Approval for Advanced Cutaneous Squamous Cell Carcinoma

Regeneron and Sanofi's Libtayo (cemiplimab) Receives European Commission's Approval for Advanced Cutaneous Squamous Cell Carcinoma

  • July 2, 2019
Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults

Teva Reports Results of Fremanezumab in P-IIIb FOCUS Study for Migraine in Adults

  • July 2, 2019
Boehringer Ingelheim Signs a License Agreement with Yuhan Corporation to Develop Dual Agonist for Nonalcoholic Steatohepatitis

Boehringer Ingelheim Signs a License Agreement with Yuhan Corporation to Develop Dual Agonist for Nonalcoholic Steatohepatitis

  • July 2, 2019
Foundation Medicine's FoundationOne CDx Receives FDA's Approval as a CDx for Lynparza (olaparib)

Foundation Medicine's FoundationOne CDx Receives FDA's Approval as a CDx for Lynparza (olaparib)

  • July 2, 2019
Varian to Acquire Boston Scientific's Oncology Assets for $90M

Varian to Acquire Boston Scientific's Oncology Assets for $90M

  • July 2, 2019
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.